Dexcom’s Record-Breaking 2023: Major Launches, Expanded Coverage, and Exceptional Financial Growth
January 9, 2024
In 2023, a continuous glucose monitor manufacturer, Dexcom, reported a significant year marked by a major product launch, the largest insurance coverage expansion in its history, and impressive financial growth. The company announced its first billion-dollar quarter at the J.P. Morgan Healthcare Conference, with a 26% increase in Q4 sales and a projected 24% annual sales growth to $3.62 billion. Dexcom also expanded its patient base by 35%. The company introduced the Stelo glucose sensor for Type 2 diabetes and expects its 2024 revenue to grow by 16-21%, reaching up to $4.35 billion.
To read more, click here.
[Source: Fierce Biotech, January 8th, 2023]
